Scientists can now interrogate cellular biology and cell-to-cell interactions in previously unachievable ways, gaining deeper insight and advancing innovative strategies for targeting cancer. In this webinar sponsored by Sartorius, a panel of experts will discuss how technological advances are driving rapid progress in disease areas such as oncology, immuno-oncology, and neuroscience.
Speakers
![](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2020/4/KimberldyWicklund.jpg) |
Kim Wicklund
Director of Product Management Sartorius
|
![](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2020/4/DanA4ppledorn.jpg) |
Dan Appledorn
Director, US Biology R&D Sartorius
|
![](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2020/4/TedHi4nchcliffe.jpg) |
Edward H. Hinchcliffe, PhD
Professor The Hormel Institute University of Minnesota
|
Topics to be covered
- Notable developments in live-cell assays and in vitro translational models
- How systems such as Incucyte® by Sartorius have enabled real-time studies of cancer cells
- How scientists are using the latest Incucyte technology in new ways